Macular ischaemia after intravitreal bevacizumab injection in patients with central retinal vein occlusion and a history of diabetes and vascular disease

Recently, there have been several reports concerning the efficacy of intravitreal bevacizumab injection (IVB) in reducing macular oedema in patients with retinal vein occlusion (RVO).1 2 According to a safety survey of IVB, adverse ocular events are extremely rare.3 At our clinic, we have performed ... View More